2018 Large Cap Biopharmaceutical Stocks : First Quarter Performance Update -

2018 Large Cap Biopharmaceutical Stocks : First Quarter Performance Update

Mar 30, 2018Jeremy ParkinsonFinance0

It has been a rough start for large cap biopharmaceutical stocks but the ETFs (FBT) and (XBI) still outperformed the SPY YTD and over 12 months. Most Individual stocks lagged unless you owned Abbvie (ABBV) or Vertex Pharmaceuticals (VRTX). Here are some key takeaways:

Buy the worst performers on technicals and valuations? BIIB CELG REGN.

Look at most stable stocks with good performance and dividends: BMY GILD.

Fidelity biotechnology fund (FBIOX) is outperforming the large cap weighted (IBB).

Over 12 months the FBT and XBI are the top performing ETFs.

Double bottom in key indices after Q1 could be a buy signal.